Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aldactone in Hypertensive Patients with Diastolic Heart Failure
NCT01944384Phase 4Completed
- Sponsor
- National Taiwan University Hospital
- Start
- Aug 2010
- Primary completion
- Dec 2010
- Modality
- Small Molecules
01
Overview
A Phase 4 trial of spironolactone in Heart failure with preserved ejection fraction (HFpEF), sponsored by National Taiwan University Hospital. Started Aug 2010; status: completed.
02
Drugs
spironolactone
03
Conditions
Heart failure with preserved ejection fraction (HFpEF)
Beyond the preview
Go deeper on NCT01944384.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01944384.